drugset / Trial / NCT00859651

Vitamin D in Postmenopausal Women at High Risk for Breast Cancer

NCT00859651

Phase 2 Completed 20 enrolled Columbia University Avon Foundation · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a phase II study which will enroll 20 postmenopausal women who are at high risk for breast cancer development. The goal is to determine whether a one-year intervention of high-dose vitamin D at 2 different doses (20,000 IU weekly or 30,000 IU weekly) will increase circulating blood levels of vitamin D and to obtain preliminary data on the biologic effects of vitamin D for breast cancer prevention.

Timeline

Start
2009-06
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 20000 iu Oral
Comparator Cholecalciferol Other / unclassified 30000 iu Oral

Indications